J01DD15 |
B |
Cefdinir - 300mg |
3851 |
194003/05 |
OMNICEF 300 |
300mg |
10 |
Capsule |
Oral |
Droguerie de l'Union |
Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan |
Jordan |
2,238,842 L.L |
23.08 |
B |
|
|
03/04/20 |
|
J01DD15 |
B |
Cefdinir - 300mg |
8839 |
87216/1 |
OMNICEF |
300mg |
10 |
Capsule |
Oral |
Droguerie de l'Union |
Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan |
Saudi Arabia |
2,238,842 L.L |
23.08 |
B |
Hikma Pharmaceuticals |
Jordan |
03/04/20 |
|
J01DD15 |
G |
Cefdinir - 300mg |
11404 |
144321/1 |
MINOCET |
300mg |
10 |
Capsule |
Oral |
Mersaco |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
1,407,003 L.L |
23.08 |
A2 |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
03/04/20 |
|
J01DD15 |
G |
Cefdinir - 300mg |
11912 |
127520/1 |
XEVANEER |
300mg |
10 |
Capsule |
Oral |
Sadco |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
1,350,562 L.L |
23.08 |
A2 |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
03/04/20 |
|